Nora

Nora Pharma is a Canadian pharmaceutical company specializing in the distribution and commercialization of generic and specialty medications across the country. As a wholly owned subsidiary of Sunshine Biopharma, the company maintains a robust portfolio of over 50 generic prescription drugs and has recently expanded into the high-growth biosimilars market. Its lead commercial milestone is the launch of NIOPEG, a biosimilar to Neulasta (pegfilgrastim), indicated for the reduction of infection incidence in patients receiving myelosuppressive chemotherapy. Nora Pharma operates a Health Canada-certified facility in the Greater Montreal area and serves as a strategic partner for pharmacy networks and healthcare providers by providing affordable, high-quality therapeutic alternatives.